One of the factors of Risk-benefit analysis according to FDA provided guidance is Patient Preference. It explains the importance of knowing any available patient preference information. Also to consider the modality of treatment/diagnostic procedure and the risk tolerance. FDA would disapprove the IDE application in accordance with 21 CFR 812.30(b), if the potential risks outweigh the anticipated benefits for all subjects.